IR 783 is a near-infrared (NIR) heptamethine cyanine fluorescent probe with excitation/emission maxima of 633/780nm, respectively[1]. IR 783 can be used in combination with anticancer drugs to enhance their targeting and therapeutic efficacy[2]. IR 783 is usually used in research related to for cell imaging and drug delivery[3][4][5].
In vitro, treatment of MDA-MB-231 and MCF-7 breast cancer cells with IR 783 (0-160µM; 0-72h) inhibited the proliferation and migration, promoted mitochondrial fission, and decreased filopodia formation in a dose- and time-dependent manner[6].
In vivo, IR 783 (20mg/kg/day; intravenous injection; 4 weeks) significantly inhibited tumor growth, increased mitochondrial translocation of Drp1, and activated the mitochondrial apoptotic pathway in an MDA-MB-231 xenograft mouse model[7].
References:
[1] Yuan J, Yi X, Yan F, et al. Nearinfrared fluorescence imaging of prostate cancer using heptamethine carbocyanine dyes. Mol Med Rep. 2015;11(2):821-828.
[2] Huang QJ, Liao GC, Zhuang XR, et al. Ras inhibitor farnesylthiosalicylic acid conjugated with IR783 dye exhibits improved tumor-targeting and altered anti-breast cancer mechanisms in mice. Acta Pharmacol Sin. 2022;43(7):1843-1856.
[3] Yang X, Shao C, Wang R, et al. Optical imaging of kidney cancer with novel near infrared heptamethine carbocyanine fluorescent dyes. J Urol. 2013;189(2):702-710.
[4] De Los Reyes-Berbel E, Salto-Gonzalez R, Ortega-Muñoz M, et al. PEI-NIR Heptamethine Cyanine Nanotheranostics for Tumor Targeted Gene Delivery. Bioconjug Chem. 2018;29(8):2561-2575.
[5] Yang X, Shi C, Tong R, et al. Near IR heptamethine cyanine dye-mediated cancer imaging. Clin Cancer Res. 2010;16(10):2833-2844.
[6] Li P, Liu Y, Liu W, et al. IR-783 inhibits breast cancer cell proliferation and migration by inducing mitochondrial fission. Int J Oncol. 2019;55(2):415-424.
[7] Tang Q, Liu W, Zhang Q, et al. Dynamin-related protein 1-mediated mitochondrial fission contributes to IR-783-induced apoptosis in human breast cancer cells. J Cell Mol Med. 2018;22(9):4474-4485.
IR 783是一种近红外(NIR)七甲川菁荧光探针,其最大激发/发射波长分别为633/780nm[1]。IR 783可以与抗癌药物联合使用,以增强其靶向性和疗效[2]。IR 783通常用于细胞成像和药物递送相关研究[3][4][5]。
在体外实验中,IR 783(0-160µM;0-72小时)处理MDA-MB-231和MCF-7乳腺癌细胞,以剂量和时间依赖的方式抑制细胞增殖和迁移,促进线粒体分裂,并减少丝状伪足形成[6]。
在体内实验中,IR 783(20mg/kg/天;静脉注射;4周)显著抑制了MDA-MB-231异种移植小鼠模型中的肿瘤生长,增加了Drp1的线粒体转位,并激活了线粒体凋亡途径[7]。
















